Webinars for Patients
NCCN Webinars for Patients feature experts as they discuss the best care for different cancer types.
Related Articles
LOAd703 Oncolytic Adenovirus Receives FDA Fast Track Designation for Pancreatic Cancer
LOAd703 has been granted FDA fast track designation for the treatment of patients with pancreatic cancer.
Beyond static measurements: dynamic frailty improves survival prediction in multiple myeloma
Abstract. The level of frailty, according to the International Myeloma Working Group frailty index, is highly dynamic during antimyeloma treatment. Dynamic
Zanidatamab Plus Evorpacept Shows Early Activity, Tolerability in Pretreated HER2+ Breast Cancer
Alberto Montero, MD, MBA, CPHQ, discusses early signals of efficacy and safety with zanidatamab plus evorpacept in HER2-positive and -low breast cancer.
Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial
CMG901 showed a manageable safety profile and had promising antitumour activity in patients with advanced gastric or gastro-oesophageal junction cancer.
Association of Hospital Market Competition with Outcomes of Complex Cancer Surgery
Annals of Surgical Oncology – The association of hospital market competition, financial costs, and quality of oncologic care has not been well-defined. This study sought…
Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial
The assumption that thermal ablation should be reserved for unresectable colorectal liver metastases requires re-evaluation and the preferred treatment should be individualised and based on…
FDA Approves Sotorasib Plus Panitumumab for KRAS G12C–Mutated Colorectal Cancer
The FDA approved sotorasib plus panitumumab for adult select patients with KRAS G12C–mutated metastatic colorectal cancer.
Managing R/R Multiple Myeloma: Current Strategies and Future Directions in Community Practice
The panelist discusses how for managing patients with R/R multiple myeloma, community clinicians should focus on personalized treatment approaches, incorporating novel therapies such as CAR…
Management of immune checkpoint inhibitor-associated toxicities in older adults with cancer: recommendations from the International Society of Geriatric Oncology (SIOG)
Immune checkpoint inhibitors (ICIs) have substantially advanced the treatment landscape for a wide variety of malignancies. Older adults represent a large and rapidly growing demographic,…
FDA Approves Acalabrutinib Plus Bendamustine and Rituximab for Previously Untreated MCL
The FDA has approved acalabrutinib plus bendamustine and rituximab for adult patients with previously untreated MCL who are ineligible for autologous HSCT.